ArticleJournal of diabetes and metabolic disorders2026
The simplified method for quantifying metabolic syndrome (siMS) score reflects an increased cardiometabolic burden: adiposity, hemodynamics, and HRV findings in young adults.
Article in Journal of diabetes and metabolic disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Quantifying Metabolic Syndrome Severity: Methodological Evolution, Clinical Validation, and Translational Perspectives.Diabetes, metabolic syndrome and obesity : targets and therapy · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Metabolic Syndrome (MetS) increases cardiovascular disease risk, yet early identification of pre-MetS remains challenging. The Simple Method for Quantifying MetS (siMS) score offers potential for detecting cardiometabolic burden in younger and middle-aged, relatively healthy populations. Methods: We stratified 51 healthy adults (aged 18-60 years) into Low siMS (LMS, siMS < 2.085, Results: The HMS group exhibited significantly higher body mass, body mass index (BMI), waist and hip circumferences, fat mass, visceral fat, central and peripheral BP, MAP, and augmentation index adjusted to 75 bpm (all Conclusion: These findings suggest that higher siMS scores reflect early cardiometabolic risk through adverse hemodynamic and autonomic profiles, even in the absence of overt MetS, metabolic abnormalities, or detectable microvascular dysfunction. The siMS score may serve as a proactive tool for identifying at-risk individuals, supporting targeted interventions to mitigate long-term cardiometabolic risk.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.